Serum or plasma TC (total cholesterol) [4], TAG (triacylglycerol) [5], HDL-C (high-density lipoprotein cholesterol) [6], LDL-C (low-density lipoprotein cholesterol) [7], Apo (apolipoprotein) A1 [8], ApoB [9] and ApoA1/ApoB ratio [10] were traditionally monitored as predictors of CHD events and the main target for therapeutic intervention. This evidence concerns the gene APOA1 and coronary artery disorder.